Medicines and Healthcare Products Regulatory Agency
London, United Kingdom
Purpose
To improve vaccine access in low- and middle-income countries by publishing a non-animal potency testing method for whole cell pertussis vaccines and supporting its adoption by national regulatory laboratories.
Division
Global Health
Date
December 2025
Region Served
GLOBAL
Committed amount
$2,689,435
Grant topic
Vaccine Development
Duration (months)
58
Grantee location
London, United Kingdom
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.